The EPS beat and cash runway extension are positive, but the stock's next major catalyst is the Phase 3 ARCHER II GA data in Q4 2026. Traders should watch for any early data disclosures or regulatory updates on the GBS BLA. The narrow loss and strong balance sheet reduce near-term dilution risk.
Price Chart
Executive Summary
Annexon reported Q1 2026 EPS of -$0.23, beating consensus of -$0.30 by 23%, with net loss narrowing to $44.1M from $54.4M a year ago. The company highlighted upcoming catalysts: Phase 3 GA data in Q4 2026, GBS BLA submission in 2026, and cash runway into H2 2027. The EPS beat and pipeline progress are positive, but the stock's reaction will hinge on clinical data readouts later this year.
Key Financial Metrics
Key Facts
- Q1 2026 EPS -$0.23 vs consensus -$0.30 (23% beat)
- Net loss $44.1M vs $54.4M YoY, narrowing 19%
- Cash, equivalents, and short-term investments $225M as of March 31, 2026
- Cash runway into H2 2027
- Phase 3 ARCHER II GA data expected Q4 2026
- GBS BLA submission planned in 2026
- R&D expenses fell to $35.8M from $48.2M YoY
Financial Impact
EPS beat of $0.07 vs consensus; net loss improved $10.2M YoY
Risk Factors
- Phase 3 ARCHER II GA trial may fail to meet endpoints
- GBS BLA submission could be delayed or rejected
- Cash runway only into H2 2027; may need future financing
- No approved products or revenue
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3290509 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 10w ago | ANALYST-UPGRADE | $5.26 $5.18 | ▼ −1.52% | ▲ +0.44% | $3.75 (−28.63%) |
Aug 12, 2026 10w ago | 8-K | $5.33 $5.50 | ▲ +3.19% | ▲ +3.63% | $3.75 (−29.56%) |
Aug 12, 2026 10w ago | Press Release | $5.33 $5.50 | ▲ +3.19% | ▲ +3.63% | $3.75 (−29.56%) |
Aug 10, 2026 10w ago | 8-K | $5.34 $5.28 | ▼ −1.12% | ▼ −0.72% | $3.75 (−29.69%) |
Aug 7, 2026 11w ago | Institutional Cluster | $5.41 $5.29 | ▼ −2.22% | ▼ −2.62% | $3.75 (−30.60%) |
Aug 6, 2026 11w ago | Press Release | $5.60 $5.26 | ▼ −6.07% | ▼ −7.28% | $3.75 (−32.96%) |
Jul 21, 2026 13w ago | ANALYST-UPGRADE | $5.39 $5.13 | ▼ −4.82% | ▼ −3.60% | $3.75 (−30.35%) |
Jul 14, 2026 14w ago | 144 | $5.55 $5.57 | ▲ +0.36% | ▲ +1.66% | $3.75 (−32.35%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.70 $4.94 | ▲ +5.11% | ▲ +4.67% | $3.75 (−20.12%) |
May 12, 2026 23w ago | ANALYST-UPGRADE | $5.44 $4.96 | ▲ +8.82% | ▲ +8.90% | $3.75 (+30.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers